Grace Therapeutics, Inc. (GRCE) Total liabilities 2022–2023
Grace Therapeutics, Inc. (GRCE) total liabilities at each fiscal year-end, per SEC filings.
$20.4MFY2023 · since FY2022: $6.8M → $20.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $20.4M | +199.4% |
| FY2022 | $6.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice